Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 01, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,700 | $9.79 | 364,180 | |
| Feb 01, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,700 | $9.77 | 359,915 | |
| Feb 01, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,700 | $9.79 | 364,180 | |
| Jun 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4/A | 1,700 | $11.48 | 8,631 | |
| Jun 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4/A | 1,700 | $11.35 | 71,002 | |
| Jun 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,700 | $11.48 | 8,631 | |
| Jun 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,700 | $11.35 | 71,002 | |
| Mar 20, 2015 | VP, Pharmacology & Biology | Open market or private sale of non-derivative or derivative security | Form 4 | 1,708 | $12.11 | 50,000 | |
| Feb 01, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,708 | $9.09 | 297,623 | |
| Feb 01, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,708 | $9.09 | 297,623 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.